SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
+5.64%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$10.3B
AUM Growth
+$1.52B
(+17%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
11.33%
Top 10 Holdings %
Top 10 Hldgs %
16.82%
Holding
2,755
New
677
Increased
586
Reduced
507
Closed
710
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$707M |
| 2 |
Intercontinental Exchange
ICE
|
+$70.5M |
| 3 |
Wells Fargo
WFC
|
+$69.7M |
| 4 |
Amazon
AMZN
|
+$63.4M |
| 5 |
M&T Bank
MTB
|
+$59M |
Top Sells
| 1 |
Ford
F
|
+$53.1M |
| 2 |
General Motors
GM
|
+$52.1M |
| 3 |
Avantor
AVTR
|
+$45.8M |
| 4 |
Synovus
SNV
|
+$41.3M |
| 5 |
KKR & Co
KKR
|
+$39.4M |
Sector Composition
| 1 | Financials | 27.23% |
| 2 | Technology | 14.02% |
| 3 | Industrials | 9.32% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Healthcare | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Royalty Pharma
RPRX
$15.5B
| $2.44M | 0.02% |
+61,290
| New | +$2.44M |
|
602
Inspirato
ISPO
$38.9M
| $2.44M | 0.02% |
12,091
| – | – |
|
603
Curis
CRIS
$21.4M
| $2.43M | 0.02% |
25,573
+21,953
| +606% | +$2.09M |
|
|
MRTX
604
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.4M | 0.02% |
16,350
-2,377
| -13% | -$349K |
|
605
Cushman & Wakefield
CWK
$3.84B
| $2.4M | 0.02% |
107,814
+82,414
| +324% | +$1.83M |
|
606
Galapagos
GLPG
$2.21B
| $2.39M | 0.02% |
+43,426
| New | +$2.39M |
|
607
Customers Bancorp
CUBI
$2.13B
| $2.39M | 0.02% |
36,600
+29,500
| +415% | +$1.93M |
|
608
ACV Auctions
ACVA
$1.93B
| $2.36M | 0.02% |
+125,337
| New | +$2.36M |
|
609
Edison International
EIX
$20.5B
| $2.36M | 0.02% |
+34,611
| New | +$2.36M |
|
610
Flowserve
FLS
$7.22B
| $2.36M | 0.02% |
77,100
-113,666
| -60% | -$3.48M |
|
611
Zillow
ZG
$21B
| $2.35M | 0.02% |
+37,821
| New | +$2.35M |
|
612
PureCycle Technologies
PCT
$2.41B
| $2.3M | 0.02% |
+240,200
| New | +$2.3M |
|
613
Boston Beer
SAM
$2.45B
| $2.29M | 0.02% |
4,525
+2,425
| +115% | +$1.22M |
|
|
HZNP
614
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.28M | 0.02% |
21,200
-47,909
| -69% | -$5.16M |
|
|
NFNT.U
615
DELISTED
Infinite Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFNT.U
| $2.27M | 0.02% |
+225,000
| New | +$2.27M |
|
616
Commercial Metals
CMC
$6.63B
| $2.25M | 0.02% |
+61,900
| New | +$2.25M |
|
617
Dropbox
DBX
$8.19B
| $2.24M | 0.02% |
91,200
+2,300
| +3% | +$56.5K |
|
|
IMDX
618
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71.3M
| $2.24M | 0.02% |
51,575
-11,973
| -19% | -$520K |
|
619
Hippo Holdings
HIPO
$916M
| $2.21M | 0.02% |
+31,280
| New | +$2.21M |
|
620
Marriott Vacations Worldwide
VAC
$2.71B
| $2.21M | 0.02% |
+13,051
| New | +$2.21M |
|
|
SPAQ
621
DELISTED
Spartan Acquisition Corp. III
SPAQ
| $2.17M | 0.02% |
220,000
+51,672
| +31% | +$510K |
|
622
Range Resources
RRC
$8.11B
| $2.15M | 0.02% |
120,700
+66,646
| +123% | +$1.19M |
|
623
Royal Gold
RGLD
$12.3B
| $2.15M | 0.02% |
20,436
+4,792
| +31% | +$504K |
|
624
A.O. Smith
AOS
$10.3B
| $2.15M | 0.02% |
25,000
-2,685
| -10% | -$230K |
|
625
Pfizer
PFE
$140B
| $2.15M | 0.02% |
36,324
-474,972
| -93% | -$28M |
|